Opioid receptors and preconditioning of the heart;Receptores opióides e pré-condicionamento isquémico do coração

Revista Portuguesa de Cardiologia

Volumn 23, Issue 10, 2004, Pages 1317-1333

  Saraiva, Joana ^a   Oliveira, Sílvia Marta ^a   Rocha Sousa, Amândio ^a   Leite Moreira, Adelino ^a  

^a University of Porto   (Portugal)

Author keywords

Ischemic preconditioning of the heart; KATP channels; NO synthases; Opioid receptors; Protein kinase C

Indexed keywords

BETA ENDORPHIN; BETA NEOENDORPHIN; DELTA OPIATE RECEPTOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DYNORPHIN A; DYNORPHIN B; ENDORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 METHIONINOL SULFOXIDE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; LEUCINE ENKEPHALIN; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 CYSTEINE]; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; METENKEPHALIN; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; MU OPIATE RECEPTOR; NITRIC OXIDE SYNTHASE; OPIATE RECEPTOR; PETHIDINE; POTASSIUM CHANNEL; PRODYNORPHIN; PROENKEPHALIN; PROTEIN KINASE C;

CARDIOVASCULAR AUTOREGULATION; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW;

HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; OPIOID PEPTIDES; RECEPTORS, OPIOID;

EID: 10644256682     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Przewlocki R, Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 2001;429:79-91.
2. North RA. Opioid receptor types and membrane ion channels. Trends Neurosci 1986;11:114-117.
3. Pugsley MK. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 2002;93:51-75.
4. Mizoguchi H, Tseng LF, Suzuki T, Sora I, Narita M. Recent advances in the search for the μ-opioidergic system; differential mechanism of G-protein activation induced by endogenous μ-opioid peptides, endomorphin and β-endorphin. Jpn J Pharmacol 2002;89:229-234.
5. Holtman SG. Phencyclidine-like discriminative effects of opioids in the rat. J Pharmacol Exp Ther 1980;214:614-619.
6. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 1991;60:653-688.
7. Stefano GB, Goumon Y, Casares F, et al. Endogenous morphine. Trends Neurosci 2002;23:436-442.
8. Stefano GB, Zhu W, Cadet P, et al. A hormonal role for endogenous opiate alkaloids: vascular tissues. Neuroendocrinol Lett 2002;23:21-26.
9. Prevot V, Rialas CM, Croix D, et al. Morphine and anadamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res 1998;790:236-244.
10. Stefano GB, Hartman A, Bilfinger TV, et al. Presence of the μ3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilatation. J Biol Chem 1995;270:30290-30293.
11. Barron BA. Opioid peptides and the heart. Cardiovasc Res 1999;43:13-16.
12. Sommerschild HT, Kirkeboen KA. Preconditioning - Endogenous defence mechanisms of the heart. Acta Anaesthesiol Scand 2002;46:123-137.
13. Raeburn CD, Zimmerman MA, Arya J, Barsness K, Harken AH. Ischemic preconditioning: fact or fantasy? J Card Surg 2002;17:536-542.
14. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-H2161.
15. Shultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996;78:1100-1104.
16. Tomai F, Crea F, Gaspardone A, et al. Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 1999;33:1836-1839.
17. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 1999;84:1396-1400.
18. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001;89:123-137.
19. Welters ID, Fimiani C, Bilfinger TV, Stefano GB. NF-kB, nitric oxide and opiate signalling. Med Hypotheses 2000;54:263-268.
20. Jugdutt BI. Nitric oxide and cardiovascular protection. Heart Fail Rev 2003;8:29-34.
21. Bolli R, Bhatti ZA, Tang XL. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 1997;81:42-52.
22. Stefano GB, Goumon Y, Bilfinger TV, Welters ID, Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a m opiate receptor. Prog Neurobiol 2000;60:513-530.
23. Schultz J el-J, Hsu AK, Nagase H, Gross GJ. Tan-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/0 proteins and KATP channels. Am J Physiol 1998;274 (Heart Circ. Physiol. 43):H909-H914.
24. Cadet P, Mantione K, Bilfinger TV, Stefano GB. Real-time RT-PCR measurement of the modulation of μ opiate receptor expression by nitric oxide in human mononuclear cells. Med Sci Monit 2001;7:1123-1128.
25. Reseine Terry, Pasternak Gavril. Chapter 23 - Opioid analgesics and antagonists. In Hardman Joel G, Limbird Lee E, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edition. International Edition, 1996:521-555.